Next Article in Journal
Structure and Function of SET and MYND Domain-Containing Proteins
Next Article in Special Issue
MicroRNA Expression Profiling of Lactating Mammary Gland in Divergent Phenotype Swine Breeds
Previous Article in Journal
Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations
Previous Article in Special Issue
Telomerase Reverse Transcriptase Regulates microRNAs
 
 
Review

Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here?

1
Department of Gynecologic Oncology and Reproductive Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
2
Institute of Pathology, University Hospital Heidelberg, Heidelberg 69120, Germany
3
Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Martin Pichler
Int. J. Mol. Sci. 2015, 16(1), 1395-1405; https://doi.org/10.3390/ijms16011395
Received: 16 December 2014 / Accepted: 30 December 2014 / Published: 8 January 2015
(This article belongs to the Collection Regulation by Non-Coding RNAs)
Recent genome-wide expression profiling studies have uncovered a huge amount of novel, long non-protein-coding RNA transcripts (lncRNA). In general, these transcripts possess a low, but tissue-specific expression, and their nucleotide sequences are often poorly conserved. However, several studies showed that lncRNAs can have important roles for normal tissue development and regulate cellular pluripotency as well as differentiation. Moreover, lncRNAs are implicated in the control of multiple molecular pathways leading to gene expression changes and thus, ultimately modulate cell proliferation, migration and apoptosis. Consequently, deregulation of lncRNA expression contributes to carcinogenesis and is associated with human diseases, e.g., neurodegenerative disorders like Alzheimer’s Disease. Here, we will focus on some major challenges of lncRNA research, especially loss-of-function studies. We will delineate strategies for lncRNA gene targeting in vivo, and we will briefly discuss important consideration and pitfalls when investigating lncRNA functions in knockout animal models. Finally, we will highlight future opportunities for lncRNAs research by applying the concept of cross-species comparison, which might contribute to novel disease biomarker discovery and might identify lncRNAs as potential therapeutic targets. View Full-Text
Keywords: functional genomics; genetically engineered mouse models (GEMM); long intergenic RNA (lincRNA); metastasis; metastasis-associated lung adenocarcinoma transcript 1 (MALAT1); HOX transcript antisense RNA (HOTAIR) functional genomics; genetically engineered mouse models (GEMM); long intergenic RNA (lincRNA); metastasis; metastasis-associated lung adenocarcinoma transcript 1 (MALAT1); HOX transcript antisense RNA (HOTAIR)
Show Figures

Figure 1

MDPI and ACS Style

Haemmerle, M.; Gutschner, T. Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here? Int. J. Mol. Sci. 2015, 16, 1395-1405. https://doi.org/10.3390/ijms16011395

AMA Style

Haemmerle M, Gutschner T. Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here? International Journal of Molecular Sciences. 2015; 16(1):1395-1405. https://doi.org/10.3390/ijms16011395

Chicago/Turabian Style

Haemmerle, Monika, and Tony Gutschner. 2015. "Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here?" International Journal of Molecular Sciences 16, no. 1: 1395-1405. https://doi.org/10.3390/ijms16011395

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop